Write My Paper Button

WhatsApp Widget

Write My Paper Button

WhatsApp Widget

Ken Fowler iHuman SOAP Note

  • iHuman SOAP Note  /  Emergency Department

    Ken Fowler — Clinical Case

    Format: SOAP Note
    Setting: Emergency Department
    Encounter Type: Acute Evaluation
    Documentation Level: Complete
    Patient Name
    Ken Fowler
    Age
    70 Years
    Sex
    Male
    Chief Complaint
    Nausea & Vomiting
    Allergies
    NKDA
    Setting
    Emergency Department

    S

    Subjective

    Chief Complaint (CC)Nausea and vomiting
    History of Present Illness (HPI)
    Ken Fowler is a 70-year-old male who presents to the ED for evaluation of elevated creatinine, having been referred by his Primary Care Provider (PCP). Prior to that PCP visit, Mr. Fowler experienced nausea and vomiting lasting 24 hours, which began after taking naproxen (an NSAID) for lower back pain sustained while carrying a load. The vomitus was clear with only residual food properties; it was aggravated by meals and relieved by decreased oral intake. For the three days preceding this presentation, he has taken nothing by mouth. The nausea and vomiting are associated with extreme fatigue, decreased urinary output, and significantly reduced oral intake.
    Current MedicationsHCTZ  |  Lisinopril  |  Metoprolol
    OTC / HerbalNaproxen (self-administered for back pain — precipitating factor)
    AllergiesNo known drug, food, or environmental allergies
    VaccinationsUp to date
    Pertinent PMHxHypertension (on HCTZ, lisinopril, metoprolol); mild chronic renal disease — creatinine 1.1; microalbuminuria (400 mg)
    Social HistoryConsumes one glass of wine with dinner once or twice per week. No tobacco or illicit drug use reported.
    Interview Questions Asked
    1. What is your name?
    2. Where are you?
    3. What time is it?
    4. What happened?
    5. How can I help you today?
    6. Have you had nausea and vomiting like this before?
    7. What does your vomit look like?
    8. Has there been any change in your nausea and/or vomiting over time?
    9. Have you been vomiting anything that looks like blood or coffee grounds?
    10. Do you have any pain or other symptoms associated with your nausea and/or vomiting?
    11. Does anything make your nausea and/or vomiting better or worse?
    12. How severe is your nausea and/or vomiting?
    13. Have you lost weight?
    14. Do you have any pain in your abdomen?
    15. Do you have frothy urine?
    16. Do you have any other symptoms or concerns we should discuss?
    17. Can you tell me about any current or past medical problems you have had?
    18. Are you taking any over-the-counter herbal medications?
    19. Do you have any allergies?
    20. Are you taking any prescription medications?
    21. Do you drink alcohol? If so, what do you drink and how many drinks per day?
    S

    Review of Systems (ROS)

    General

    + Nausea, vomiting
    − Chills, fevers, night sweats, sore throat

    Cardiovascular / PVS

    − Palpitations, edema (upper/lower/facial), chest pain, SOB, cold/blue fingers

    Respiratory

    − Cough, wheezing, SOB, DIB

    Gastrointestinal

    + Nausea, vomiting, decreased appetite
    − Constipation, diarrhea, change in stool color

    Genitourinary

    + Decreased urine output
    − Pain, burning, urgency, frequency, incontinence

    Musculoskeletal

    − Back pain, muscle/joint pain or swelling, joint stiffness

    Psychiatric

    − Sadness, depression, mood changes, lack of interest, nervousness

    Neurologic

    − Tremors, numbness, tingling, weakness, fainting, dizziness

    Endocrine

    + Decreased appetite
    − Increased sweating, increased thirst, cold/heat intolerance

    Hematologic / Lymphatic

    − Easy bleeding/bruising, bleeding gums or nosebleeds

    Allergic / Immunologic

    − Environmental, food, or drug allergies

    O

    Objective

    Vital Signs
    BP
    108/62
    HR (Apical)
    98 bpm
    RR
    17
    O₂ Sat
    99% (LA)

    Note: Hypotension and tachycardia consistent with volume depletion / prerenal pathology.

    Physical Examination Findings
    Patient is alert and oriented ×4, in no acute pain or respiratory distress.
    Eyes: PERRLA, no conjunctival pallor. Ears: no discharge, sharp optic discs, bilateral red reflex. Nose/Mouth/Throat: mucous membranes are dry.
    Soft and non-distended. Bowel sounds present in all four quadrants. No palpable masses or lumps. Mild periumbilical tenderness noted.
    Tests Ordered & Diagnostics
    Renal UltrasoundComplete Blood Count (CBC)Urine EosinophilsUrine Sodium (Na+)Basic Metabolic Panel (BMP)Urinalysis (UA)Pelvic Ultrasound
    A

    Assessment

    Primary Diagnosis
    Primary Diagnosis  ·  ICD-10: N17.9
    Acute Kidney Failure, Unspecified — Prerenal Azotemia (Uremia)

    Ken Fowler presented with elevated creatinine, nausea, and vomiting following self-administration of naproxen, an NSAID, for back pain. The nausea and vomiting were accompanied by extreme fatigue, significantly reduced oral intake, and decreased urine output. The chronological sequence of events — back injury, naproxen use, GI symptoms, oliguria, and referral for elevated creatinine — points to acute kidney injury with naproxen as the primary causative agent. NSAIDs such as naproxen are nephrotoxic through COX inhibition, which reduces prostaglandin-mediated afferent arteriolar dilation, thereby decreasing glomerular filtration pressure and precipitating prerenal acute kidney injury (Hoste et al., 2018). Physical exam findings of hypotension (108/62), tachycardia (HR 98), dry mucous membranes, prolonged blanching time, and periumbilical tenderness collectively corroborate a prerenal etiology secondary to volume depletion and NSAID nephrotoxicity.

    Differential Diagnoses
    Medication-Related Side EffectICD-10: 995A

    Mr. Fowler reports that nausea and vomiting followed his self-initiated naproxen use for back pain. Naproxen inhibits COX-1 and COX-2 enzymes, reducing prostaglandin synthesis. This reduction causes renal ischemia, decreased glomerular pressure, and heightened risk of acute kidney injury, particularly in a patient with pre-existing mild chronic renal disease and hypertension.

    Acute Nephritic SyndromeICD-10: N00.9

    Patients with acute nephritic syndrome may present with elevated creatinine, oliguria, fatigue, nausea, vomiting, periumbilical tenderness, and anorexia (Bhalla et al., 2019). However, this diagnosis typically follows a recent systemic illness, which Mr. Fowler does not report. Additionally, pedal edema, facial edema, and periorbital edema — common in nephritic syndrome — are absent on physical examination, making this a less likely diagnosis.

    Urinary ObstructionICD-10: N13.9

    Patients with urinary obstruction commonly report decreased urine output (oliguria), hesitancy, and abdominal pain. Mr. Fowler’s advanced age, history of mild chronic renal disease, and underlying hypertension are recognized risk factors. However, he denies hesitancy, dribbling, or difficulty initiating or stopping urination, and no urethral or bladder pathology was identified on exam, reducing the clinical probability of this diagnosis (Serlin, Heidelbaugh & Stoffel, 2018).

    P

    Plan

    Admission Details
    Admit ToMedical-Surgical Unit
    AllergiesNone / NKDA
    DietLow-sodium diet
    ActivityMild physical activity (e.g., ambulation / walking)
    ConsultsRenal specialist (nephrology consultation)
    Nursing Orders
    • Initiate IV rehydration therapy with normal saline (NS) until restoration of adequate intravascular volume (Moore, Hsu & Liu, 2018).
    • Hold HCTZ and lisinopril — both medications are contraindicated in the setting of acute dehydration and prerenal AKI.
    • Discontinue NSAIDs (naproxen) immediately — primary nephrotoxic agent.
    • Insert Foley catheter to accurately monitor urine input/output.
    • Consult dietitian regarding appropriate dietary planning for a patient with concurrent hypertension and mild chronic renal disease.
    Medications / Interventions
    No new pharmacologic agents initiated at this time. Management is primarily supportive: IV fluid resuscitation, removal of nephrotoxic agents, and hemodynamic monitoring. Reassess renal function post-rehydration before resuming any antihypertensives.
    Laboratory Orders
    Serial BMP monitoring to track creatinine trends, electrolyte balance, and BUN levels. Repeat urinalysis as clinically indicated. Monitor urine output hourly via Foley.
    Patient Education
    • Avoid self-medicating with OTC drugs, especially NSAIDs. Because you take medications for high blood pressure, drug interactions are a real concern. Always consult your PCP before starting any OTC, prescription, or herbal medication (Moore, Hsu & Liu, 2018).
    • Maintain a DASH diet and adhere consistently to your antihypertensive medication regimen for adequate blood pressure control.
    • Monitor your urine output at home — report any notable decreases or changes in color promptly to your provider.
    • Ensure adequate daily fluid intake unless otherwise instructed by your care team, particularly during episodes of illness or reduced appetite.
    Follow-Up / Disposition
    • Return immediately to the ED if similar symptoms recur or new symptoms develop.
    • Follow-up appointment in 2 weeks post-discharge to evaluate renal function recovery and blood pressure control.
    Health Maintenance & Preventive Health
    Advise patient to maintain up-to-date immunization schedule. Reinforce importance of regular preventive care visits given comorbidities of hypertension and chronic kidney disease stage II.
    REF

    References

    • Bhalla, K., Gupta, A., Nanda, S., & Mehra, S. (2019). Epidemiology and clinical outcomes of acute glomerulonephritis in a teaching hospital in North India. Journal of Family Medicine and Primary Care, 8(3), 934. https://doi.org/10.4103/jfmpc.jfmpc_404_18
    • Hoste, E. A., Kellum, J. A., Selby, N. M., Zarbock, A., Palevsky, P. M., Bagshaw, S. M., & Chawla, L. S. (2018). Global epidemiology and outcomes of acute kidney injury. Nature Reviews Nephrology, 14(10), 607–625. https://doi.org/10.1038/s41581-018-0052-0
    • Moore, P. K., Hsu, R. K., & Liu, K. D. (2018). Management of acute kidney injury: core curriculum 2018. American Journal of Kidney Diseases, 72(1), 136–148. https://doi.org/10.1053/j.ajkd.2017.11.021
    • Serlin, D. C., Heidelbaugh, J. J., & Stoffel, J. T. (2018). Urinary retention in adults: evaluation and initial management. American Family Physician, 98(8), 496–503. https://www.aafp.org/pubs/afp/issues/2018/1015/p496.html

    Assignment Week:

    Course: Advanced Health Assessment / NR509 or NR511 (or equivalent clinical reasoning course) Assignment Title: iHuman Clinical Reasoning Reflection — Care Planning and Patient Safety in Acute Kidney Injury

    Overview / Description:

    Building on the Ken Fowler iHuman encounter, this follow-up written assignment asks you to move beyond diagnosis into evidence-based clinical reasoning, interprofessional care coordination, and patient safety analysis. In a 900-to-1,200-word APA-formatted paper, reflect on and analyze the clinical decision-making process demonstrated in the Ken Fowler case, with a specific focus on how the patient’s medication history, comorbidities (hypertension and CKD stage II), and NSAID use collectively increased his risk for acute kidney injury. Your paper must identify at least two patient safety concerns relevant to this case, propose interprofessional interventions (including nephrology, nursing, pharmacy, and dietetics roles), and apply at least one evidence-based clinical practice guideline — such as the KDIGO AKI guidelines — to justify your management decisions. You are required to include a minimum of three peer-reviewed references published within the past five years, formatted in APA 7th edition with DOIs. This assignment is worth 20% of your total course grade and is due at the end of Week 6 via the course LMS submission portal.

    Requirements at a Glance:

    • 900–1,200 words, APA 7th edition format
    • Minimum 3 peer-reviewed references (2020–2025), with DOIs
    • Address: medication reconciliation, CKD risk stratification, NSAID contraindications, interprofessional roles, and KDIGO guideline application
    • Submit as a Word document (.docx) through the LMS by 11:59 PM on the due date